Neoplasms of the Prostate (DBCOND0080047)

Identifiers

Synonyms
Neoplasm, Prostate / Prostate Neoplasms / Neoplasm prostate / Neoplasms Prostate / Prostate Neoplasm / Neoplasms, Prostate / Neoplasms of Prostate / Neoplasms, Prostatic / Neoplasm,Prostatic / Prostatic Neoplasm / Prostatic Neoplasms / Neoplasm of the prostate / Neoplasm of prostate / Prostatic neoplasm NOS / Prostate neoplasia / Neoplasm of prostate (disorder)

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT02680535
MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate TissueNo drug interventionstreatmentNot Availablecompleted
NCT04240639
An Extension Study MRI/US Fusion Imaging and Biopsy in Combination With Nanoparticle Directed Focal Therapy for Ablation of Prostate TissueNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT03149861
Detection of Clinically Significant Prostate Cancer With 18F-DCFPyL PET/MRNo drug interventionsdiagnosticNot Availableactive_not_recruiting
NCT05422911
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.treatment2not_yet_recruiting
NCT01553188
AMG 386 and Abiraterone for Advanced Prostate Cancertreatment2completed
NCT01819285
Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate CancerNo drug interventionstreatment3completed
NCT03322020
Androgen Deprivation Therapy, External Beam Radiotherapy and Stereotactic Radiosurgery Boost for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT03344757
Health Gatherings - For Your Health After CancerNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT03572387
A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatmenttreatment2completed
NCT00910754
A QT/QTc and Multi-Dose Pharmacokinetic Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancertreatment1completed
NCT00474383
An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapytreatment2completed
NCT04633252
M9241 in Combination With Docetaxel in Adults With Metastatic Castration Sensitive and Castration Resistant Prostate Cancertreatment1 / 2recruiting
NCT01477749
Sipuleucel-T Manufacturing Demonstration StudyNot Available2completed
NCT03388619
Highly Conformal, Hypofractionated, Focally Dose Escalated Post-Prostatectomy RadiotherapyNo drug interventionstreatment1active_not_recruiting
NCT01695135
A Study of Abiraterone Acetate Plus Prednisone in Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Docetaxel-Based Chemotherapytreatment3completed
NCT01017939
A Drug-Drug Interaction Study of Abiraterone Acetate Plus Prednisone With Dextromethorphan and Theophylline in Patients With Metastatic Castration-Resistant Prostate Cancertreatment1completed
NCT01424930
A Study to Determine the Short-Term Safety of Continuous Dosing of Abiraterone Acetate and Prednisone in Modified Fasting and Fed States to Patients With Metastatic Castration-Resistant Prostate Cancertreatment2completed
NCT01284920
A Study of MDV3100 to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of in Prostate Cancer Patientstreatment1 / 2completed
NCT03531827
Combining CRLX101, a Nanoparticle Camptothecin, With Enzalutamide in People With Progressive Metastatic Castration Resistant Prostate Cancer Following Prior Enzalutamide Treatmenttreatment2terminated
NCT01228760
A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate CancerNo drug interventionstreatment1completed
NCT00102544
Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresNo drug interventionsdevice_feasibilityNot Availableenrolling_by_invitation
NCT02759744
Fusion Guided Focal Laser Ablation of Prostate CancerNo drug interventionsdevice_feasibilityNot Availablesuspended
NCT03181867
18F-DCFPyL PET/CT in High Risk and Recurrent Prostate Cancerdiagnostic2enrolling_by_invitation
NCT00298155
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancertreatment2completed
NCT02649855
Docetaxel and PROSTVAC for Metastatic Castration-Sensitive Prostate Cancertreatment2completed
NCT04703543
Evaluating the Role of Both PSMA and 64Cu-PET/CT Total Body in Patients With Locally Relapsed Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00425503
PS-341 Followed by Removal of Prostate for Those With Prostate Cancertreatment2completed
NCT02334579
Stereotactic Body Radiotherapy for Stage I-III Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT01217697
Study of Abiraterone Acetate in Patients With Advanced Prostate CancerNot AvailableNot Availableapproved_for_marketing
NCT01692483
Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate CancerNot AvailableNot Availablewithdrawn
NCT01664728
An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001treatment1completed
NCT01834209
A Study of Abiraterone Acetate Plus Prednisone in Asymptomatic or Mildly Symptomatic Patients With Metastatic Castration-Resistant Prostate CancerNot AvailableNot Availableno_longer_available
NCT00972309
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate CancerNo drug interventionstreatment1completed
NCT01715285
A Study of Abiraterone Acetate Plus Low-Dose Prednisone Plus Androgen Deprivation Therapy (ADT) Versus ADT Alone in Newly Diagnosed Participants With High-Risk, Metastatic Hormone-Naive Prostate Cancer (mHNPC)treatment3completed
NCT01581749
Evaluation of Truebeam for Low-Intermediate Risk Prostate CancerNo drug interventionstreatment4unknown_status
NCT02582749
Androgen Deprivation Therapy +/- Radium-223 Dichloride in Metastatic Prostate Cancer With Bone Metastasestreatment2terminated
NCT00643617
CyberKnife Radiosurgery For Low & Intermediate Risk Prostate Cancer: Emulating HDR Brachytherapy DosimetryNo drug interventionstreatmentNot Availablecompleted
NCT03173924
18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancerdiagnostic2active_not_recruiting
NCT00600535
A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancertreatment1completed
NCT02319239
Prostate Cancer Stereotactic RadiotherapyNo drug interventionstreatmentNot Availablecompleted
NCT00167648
Neoadjuvant Estradiol or Androgen Deprivation in Clinically Localized Prostate Cancertreatment2completed
NCT02900248
CureOne Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician ChoiceNo drug interventionsNot AvailableNot Availableterminated
NCT00999960
Study to Evaluate the Clinical Impact of a Laparoscopic Radical Prostatectomy SimulatorNo drug interventionsotherNot Availablesuspended
NCT00643994
CyberKnife Radiosurgery for Organ-Confined Prostate Cancer: Homogenous Dose DistributionNo drug interventionstreatmentNot Availablecompleted
NCT03685591
PF-06952229 Treatment in Adult Patients With Advanced Solid Tumorstreatment1terminated
NCT05577689
Novel Therapy Target in Metastatic Prostate CancerNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT00544440
An Observational Study of Continuous Oral Dosing of Abiraterone Acetate in Castration-Resistant Prostate Cancer Patients Evaluating Androgens and Steroid Metabolites in Bone Marrow Plasmatreatment2completed
NCT00473746
Abiraterone Acetate Dose-Escalation Study in Hormone Refractory Prostate Cancertreatment1 / 2completed
NCT01400555
A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)No drug interventionstreatment1completed
NCT00970203
Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancertreatment2completed
NCT02652000
Quality of Life After Permanent Interstitial Iodine Seed Prostate BrachytherapyNo drug interventionsNot AvailableNot Availablecompleted
NCT01371513
Korean Practice Patterns for Screening PCA(Prostate Cancer)No drug interventionsNot AvailableNot Availablecompleted
NCT00883909
ARI103094-Follow-Up Study for REDUCE Study SubjectsNot AvailableNot Availablecompleted
NCT00056407
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Riskprevention3completed
NCT04249947
P-PSMA-101 CAR-T Cells in the Treatment of Subjects With Metastatic Castration-Resistant Prostate Cancer (mCRPC) and Advanced Salivary Gland Cancers (SGC)treatment1active_not_recruiting
NCT00363311
Assessment Of Dutasteride (AVODART) In Extending The Time To Progression Of Low-Risk, Localized Prostate Cancer In Mentreatment4completed
NCT00148928
Safety & Activity of P501-AS15 Vaccine as a First-line Treatment for Patients With Hormone-sensitive Prostate Cancer Who Show Rising PSANo drug interventionsprevention1completed
NCT02381990
MRI/Ultrasound Fusion Guided Prostate CryotherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT05241236
MRI/Ultrasound Fusion Guided Laser Ablation of Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT02349139
Safety, Preliminary Efficacy and Pharmacokinetics of ASN001 in Metastatic Castrate Resistant Prostate CancerNo drug interventionstreatment1terminated
NCT02153918
Vaccine Plus Booster Shots in Men With Prostate Cancer Undergoing Treatment With Radical ProstatectomyNo drug interventionstreatment2completed
NCT01337258
Economic Analyses of the REDUCE TrialNot AvailableNot Availablecompleted
NCT00558363
ARTS - AVODART After Radical Therapy For Prostate Cancer Studytreatment2completed
NCT00470834
Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapytreatment4completed
NCT04124107
Unfavorable MRI But Favorable 68Ga-PSMA PET/MRI for Primary Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availableunknown_status
NCT04053842
Multi-modality Imaging (PCa) Using Sodium MRI and PSMA PET in Men Pre-prostatectomyNo drug interventionsdiagnostic2recruiting
NCT04045717
Hypofractionated Focal Lesion Ablative Microboost in prostatE Cancer 2.0No drug interventionstreatment2active_not_recruiting
NCT02787434
Addressing Prostate Cancer Information Disparities With eHealth TechnologyNo drug interventionsscreeningNot Availablecompleted
NCT04852224
Strength, Aging, and Memory in Prostate CancerNot AvailableNot Availablecompleted
NCT04541225
Study of NUV-422 in Adults With Recurrent or Refractory High-grade Gliomas and Solid TumorsNo drug interventionstreatment1terminated
NCT02485665
Efficacy of Extracorporeal Biofeedback Device for Post-prostatectomy IncontinenceNo drug interventionssupportive_careNot Availableunknown_status
NCT01630967
Efficacy Study of Switching to a Lutenizing Hormone-releasing Hormone (LHRH) Antagonist From a LHRH Agonist to Treat Progressive Castrate Resistant Prostate Cancer (CRPC)treatment2unknown_status
NCT03572946
Targeted Biopsy or Standard Biopsy for Clinical Significant Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availableunknown_status
NCT05460312
Protein Kinase A in Prostate Cancer Tissue.No drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT06223295
Effectiveness of Focal Therapy in Men With Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT06315595
Improvements in Dynamic Contrast-Enhanced MR Angiography and PerfusionNo drug interventionsNot AvailableNot Availablerecruiting
NCT03828838
Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancertreatment1 / 2completed
NCT04792138
Learning MRI and Histology Image Mappings for Cancer Diagnosis and Prognosis.No drug interventionsNot AvailableNot Availableunknown_status
NCT06020287
The Robot-Assisted Laparoscopic Radical Prostatectomy Combined Anterior and Posterior ApproachNo drug interventionsNot AvailableNot Availablecompleted
NCT03819751
MRI-targeted Biopsy of the Prostate: Software Versus Visual Registration in the Accuracy of Prostate Cancer DetectionNo drug interventionsdiagnosticNot Availablerecruiting
NCT01240551
F-18 Sodium Fluoride in Prostate Cancerdiagnostic2completed
NCT03431753
Early and Accurate Detection of Prostate Cancer in General PracticeNo drug interventionsdiagnosticNot Availableunknown_status
NCT03493945
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)treatment1 / 2active_not_recruiting
NCT03458598
Pre-Operative Single Shot Rectus Sheath BlockNo drug interventionstreatmentNot Availablecompleted
NCT05422105
Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer PatientNo drug interventionsNot AvailableNot Availablerecruiting
NCT04075305
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT06292897
Using Tissue-based Spatial Data to Understand How Obesity-related Tumor Metabolites Fuel Prostate Cancer ProgressionNo drug interventionsNot AvailableNot Availablerecruiting
NCT00805883
MRI Targeted Focal Laser Thermal Therapy of Prostate Cancer Followed by Radical ProstatectomyNo drug interventionstreatment1completed
NCT05137561
Robotic-arm Assisted 68 Ga PSMA PET/CT Guided Prostate Biopsy Versus MR Directed TRUS Guided Prostate BiopsyNo drug interventionsdiagnosticNot Availableunknown_status
NCT06430411
Outcomes of Local Treatment for Oligometastatic Prostate Cancer Diagnosed Using PSMA PET Imaging: OLIGOMET StudyNot AvailableNot Availablenot_yet_recruiting
NCT03241537
COHORT Trial in Clinical Pelivc Lymph Node Metastatic Prostate CancerNo drug interventionstreatment3active_not_recruiting
NCT03321149
Reducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT05191017
Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPCtreatment1 / 2withdrawn
NCT05373316
Addition of a Focal Boost in External Beam Radiotherapy for Locally Advanced Prostate Cancer by Online Adaptive MR-guided RadiotherapyNo drug interventionstreatment2not_yet_recruiting
NCT00005916
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate CancerNo drug interventionstreatment2completed
NCT03702439
Prostate Cancer Screening Trial Using ImagingNo drug interventionsNot AvailableNot Availablecompleted
NCT02436122
Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00255125
Role of Soy Supplementation in Prostate Cancer DevelopmentNo drug interventionsprevention3completed
NCT04019327
A Study of the Drugs Talazoparib and Temozolomide in Prostate Cancertreatment1 / 2active_not_recruiting
NCT02380027
PRostate Evaluation for Clinically Important Disease: Sampling Using Image-guidance Or Not?No drug interventionsdiagnostic3completed
NCT03822494
CyberKnife Dose Escalation Prostate Cancer TrialNo drug interventionstreatmentNot Availablerecruiting
NCT02225262
A Phase II Trial of CyberKnife Stereotactic Radiosurgery to Prostate TumorsNo drug interventionstreatmentNot Availableunknown_status
NCT05710380
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted BiopsyNo drug interventionsscreeningNot Availablerecruiting
NCT05276492
Decreasing Dosing Regimens of Abiraterone 500 mg in Men With Prostate Cancer to Find Lowest Recommended Dose.treatment1active_not_recruiting
NCT03424850
Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyNo drug interventionstreatment1 / 2recruiting
NCT04376008
A Prospective Study Of Free-Hand Transperineal Image Fusion Targeted Biopsies Under Local AnesthesiaNo drug interventionsdiagnosticNot Availablecompleted
NCT04030338
Prostate-Specific Membrane Antigen (PSMA) PET Scans in People Prostate CancerNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT02809690
18F-FMAU PET/CT in Diagnosing and Characterizing Prostate Cancerdiagnostic1terminated
NCT05252390
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumorstreatment1 / 2recruiting
NCT03232164
PSMA-based 18F-DCFPyL PET/CT and PET/MRI Pilot Studies in Prostate Cancerdiagnostic0recruiting
NCT03321864
Capture of Prostatic Trans-rectal Ultrasound Scans for ResearchNo drug interventionsbasic_scienceNot Availablesuspended
NCT02362464
Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139No drug interventionstreatment2completed
NCT03389451
68Ga PSMA PET for Patients With Biochemical Recurrence of Prostate Cancerdiagnostic2 / 3completed
NCT00252447
Preop Conformal Radiotherapy - ProstateNo drug interventionstreatment1 / 2completed
NCT05849298
A Phase II Study of AAA617 Alone and AAA617 in Combination With ARPI in Patients With PSMA PET Scan Positive CRPCtreatment2recruiting
NCT05129605
Prostate Cancer Genetic Risk Evaluation and Screening StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT03952793
Organoids From Metastases of Prostate CancerNo drug interventionsbasic_scienceNot Availableterminated
NCT04831307
68Ga-HTK03149 for Use as a Diagnostic RadiopharmaceuticalNo drug interventionsotherNot Availableunknown_status
NCT03104907
Prostatic Artery Embolization for Obstructive Uropathy Due to Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03947515
Urinary and Prostate Microbiotes and Prostate CancerNo drug interventionsbasic_scienceNot Availablecompleted
NCT06059859
Impact of Augmented Reality During Robot-assisted Radical ProstatectomyNo drug interventionstreatmentNot Availablerecruiting
NCT01314118
IMAAGEN: Impact of Abiraterone Acetate in Prostate-Specific Antigentreatment2active_not_recruiting
NCT02967458
Detection of High Grade Prostate Cancer With Subharmonic Ultrasound Imaging, A Pilot Studydiagnostic2completed
NCT02966535
The Effect of Prolonged Inspiratory Time on Gas Exchange During Robot-assisted Laparoscopic Surgery With Steep Trendelenburg Position : A Crossover Randomized Clinical TrialNo drug interventionstreatmentNot Availablecompleted
NCT00660686
Exercise for Physical Health in Men With Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT01696539
Steps for PRosTAte Cancer Health and Survival (SPaRTACuS): Pilot Study of a Walking Intervention to Improve Health and Quality of Life in Prostate Cancer PatientsNo drug interventionssupportive_careNot Availablecompleted
NCT03348722
Active Surveillance or Radical Treatment for Newly Diagnosed Patients With a Localized, Low Risk, Prostate Cancer STARTNo drug interventionsNot AvailableNot Availablecompleted
NCT04462926
Evaluation of Diagnostic Accuracy of [68Ga]Ga-PSMA-11 PET/CT in Primary Staging of Intermediate and High Risk Prostatic Cancer in Men Newly DiagnosedNo drug interventionsdiagnosticNot Availablerecruiting
NCT00666926
Study Of PF-00562271, Including Patients With Pancreatic, Head And Neck, Prostatic NeoplasmsNo drug interventionstreatment1completed
NCT03242265
Measurement of Natural Killer Cell Activity in Whole Blood in Men Being Screened for Prostate Cancer With BiopsyNo drug interventionsscreeningNot Availableterminated
NCT06046131
Clinical, Genetic and Environmental Determinants of Prostate Cancer Progression.No drug interventionsotherNot Availablerecruiting
NCT04266431
EMPOWER Men to Reduce Weight and Inhibit Prostate Cancer ProgressionNo drug interventionspreventionNot Availableactive_not_recruiting
NCT05162573
EBRT + Lu-PSMA for N1M0 Prostate Cancertreatment1recruiting
NCT01540994
Stereotactic Body Radiation Therapy (SBRT) for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT01431391
Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancertreatment2completed
NCT02526589
Does Bloody Urine Predict Urethrovesical Anastomosis Leakage After Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT06236789
Observation Study to Evaluate the Efficacy and Safety of Ifosfamide/Mesna in Patients With Metastatic Castration-resistant Prostate CancerNot AvailableNot Availablerecruiting
NCT03183544
Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold KitNo drug interventionsdiagnostic1completed
NCT05968144
Towards Understanding Between ADT Treatment, Circadian Rhythm, and Physiological ResponsivenessNo drug interventionssupportive_care1 / 2recruiting
NCT00001444
A Phase I Trial of Continuous Infusion UCN-01 in Patients With Refractory Neoplasmstreatment1completed
NCT04484701
[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate CancerNot AvailableNot Availablerecruiting
NCT00247312
Pd-103 Dose De-Escalation for Early Stage Prostate Cancer: A Prospective Randomized TrialNo drug interventionsNot Available3completed
NCT02687308
Open Anterograde Radical Prostatectomy Compared to Open Retrograde TechniqueNo drug interventionstreatmentNot Availablecompleted
NCT03490838
177Lu-PSMA-R2 in Patients With PSMA Positive Progressive, Metastatic, Castration Resistant Prostate Cancertreatment1terminated
NCT04854343
SLPI for Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT03061643
An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinomatreatment2unknown_status
NCT02729103
Treatment Patterns in Metastatic Prostate CancerNot AvailableNot Availablecompleted
NCT00751790
Efficacy and Safety of a Triptorelin 6-month Formulation in Patients With Advanced Prostate Cancertreatment3completed
NCT03035487
Urology of Virginia Case SeriesNo drug interventionsdevice_feasibilityNot Availablecompleted
NCT04774133
The Immunodynamic Effect of Radiotherapy in Prostate Cancer Patients.No drug interventionstreatmentNot Availableunknown_status
NCT00126854
High Field Magnetic Resonance Spectroscopy Imaging for Follow Up of Prostate Cancer Post Brachytherapy ImplantationNo drug interventionsdiagnosticNot Availablecompleted
NCT05566405
The Effects of Method of Anaesthesia on the Safety and Effectiveness of Radical Retropubic ProstatectomyNo drug interventionstreatmentNot Availablecompleted
NCT00956228
Study of Radioimmunoguided Intensity Modulated Radiotherapy (IMRT) for Prostate CancerNo drug interventionstreatment1 / 2completed
NCT04221828
Trial of NanoPac Focal Therapy for Prostate Cancertreatment2terminated
NCT03343093
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer SurvivorsNo drug interventionssupportive_careNot Availablecompleted
NCT03693742
MSG Use With 18F-DCFPyL PET/CT ImagingNo drug interventionsdiagnosticNot Availablecompleted
NCT04234399
Determination of the Diagnostic Detection Rate of Axumin (Fluciclovine) Digital PET/CT, Post-prostatectomyNo drug interventionsNot AvailableNot Availableterminated
NCT05667636
Early Salvage Stereotactic Radiotherapy for Biochemical Failure After RPNo drug interventionstreatment2recruiting
NCT01337518
A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate CancerNo drug interventionstreatment1suspended
NCT05612841
A Study on Drug-drug Interactions in Patients Treated With Anticancer Agents for a Prostate Cancer in Real Life SettingNo drug interventionsNot AvailableNot Availablerecruiting
NCT05786716
DETERMINE Trial Treatment Arm 04: Trastuzumab in Combination With Pertuzumab in Adult, Teenage/Young Adult and Paediatric Patients With Cancers With HER2 Amplification or Activating Mutationstreatment2 / 3recruiting
NCT01996696
Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the Prostatetreatment2terminated
NCT04523896
HDR Brachytherapy Plus Stereotactic Ablative Prostate Radiotherapy for Patients With Intermediate and High-risk Prostate CancerNo drug interventionstreatment2unknown_status
NCT01316458
Glivec in Prostate Cancer Patients With Rising PSA Following Radical Prostectomytreatment2completed
NCT00174863
Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate CancerNo drug interventionstreatment2completed
NCT03397030
Impact of Exercise on Prognostic Biomarkers Related to Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT03289130
Dietary Factors and Racial Disparities in Prostate Cancer AggressivenessNo drug interventionsNot AvailableNot Availablecompleted
NCT00001266
A Phase II Trial of Leuprolide + Flutamide + Suramin in Untreated Poor Prognosis Prostate Carcinomatreatment2completed
NCT03935282
Assessing Effectiveness and Implementation of an EHR Tool to Assess Heart Health Among SurvivorsNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04398173
Detection Rate of Prostate Cancer in Men Undergoing MRINo drug interventionsNot AvailableNot Availablecompleted
NCT01081873
Study to Document Treatment Patterns and to Evaluate Leuprolide and Alternative Therapeutic Approaches to the Treatments of Advanced Prostate CancerNot AvailableNot Availablecompleted
NCT00252460
CT/MRI Co-registration Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03939689
Study of I-131-1095 Radiotherapy in Combination With Enzalutamide in Patients With Metastatic Castration-resistant Prostate Cancer Who Are Chemotherapy Naive and Have Progressed on Abirateronetreatment2active_not_recruiting
NCT03253744
Prostate SBRT for Locally Recurrent Prostate Cancer After Prior Radiotherapytreatment1active_not_recruiting
NCT03361969
Evaluation of Effects of Estetrol on Testosterone Suppression and Quality of Life in Prostate Cancer Patients Treated With an LHRH Agonist.treatment2completed
NCT00001446
A Randomized Phase II Study of Oral Thalidomide in Patients With Hormone-Refractory Prostate Cancertreatment2completed
NCT03388346
68Ga PSMA in Preprostatectomy Patientsdiagnostic2 / 3completed
NCT03982095
Survey on Lifestyle, Perceived Barriers and Development of Change in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT02971995
Trimodal (18)F-choline-PET/mpMRI/TRUS Targeted Prostate BiopsiesNo drug interventionsdiagnosticNot Availablecompleted
NCT02977143
Positive End-expiratory Pressure-induced Increase in Central Venous Pressure as a Predictor of Fluid Responsiveness in Robot-assisted Laparoscopic SurgeryNo drug interventionsdiagnosticNot Availablecompleted
NCT03693703
Comparison of Multi-parametric and Bi-parametric Magnetic Resonance Imaging in Men With Suspicion of Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT02311764
Carboplatin in Castration-resistant Prostate Cancertreatment2terminated
NCT03428087
Prostate Impendance Test ProjectNo drug interventionsNot AvailableNot Availableunknown_status
NCT00477087
Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate Cancertreatment2terminated
NCT00271687
A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate CancerNo drug interventionstreatment2completed
NCT03066154
Oral Docetaxel (ModraDoc/r) in Combination With Hormonal Treatment and Radiation Therapy in High-risk Prostate Cancertreatment1terminated
NCT06457854
Real-life Experience in Brazil in Patients With Castration-resistant Prostate Cancer Treated With Olaparib+AbirateroneNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02362451
Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Men With Stage D0 Prostate CancerNo drug interventionstreatment2terminated
NCT00096551
A Phase I Feasibility Study of an Intraprostatic PSA-Based Vaccine in Men With Prostate Cancer With Local Failure Following Radiotherapy or Cryotherapy or Clinical Progression on Androgen Deprivation Therapy in the Absence of Local Definitive TherapyNo drug interventionstreatment1completed
NCT00593853
Efficacy Study of Methylphenidate Hydrochloride to Reduce Fatigue in Prostate Cancer Patients Receiving Hormone Therapytreatment2terminated
NCT00160953
Endorectal Coil Magnetic Resonance Images (ERC-MRI)No drug interventionsprevention2completed
NCT00569153
Safety Study of TAK-700 in Subjects With Prostate Cancer.treatment1 / 2completed
NCT02341677
SmartTarget: BIOPSYNo drug interventionsdiagnosticNot Availablecompleted
NCT02940977
Establishment and Clinical Assessment of a Prostate Cancer (PCa) Risk Model Based on the Updated Circulating Tumor Cell (CTC) Detection TechniqueNo drug interventionsNot AvailableNot Availableunknown_status
NCT00855647
Hypofractionated Radiotherapy for Localized Prostate Cancer (With CyberKnife or With IMRT)No drug interventionstreatment2completed
NCT05574647
Imperial Prostate 7 - Prostate Assessment Using Comparative Interventions - Fast Mri and Image-fusion for CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT02266745
A Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in Subjects With Advanced Solid Tumors and Subsequent Dose Expansion Cohortstreatment2active_not_recruiting
NCT03822845
Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancerdiagnostic2 / 3active_not_recruiting
NCT05787145
ComCancer: Use of Let's Discuss Health Website by Patients With Prostate Cancer Undergoing Radiation Oncology TreatmentNo drug interventionsotherNot Availablerecruiting
NCT00280098
Docetaxel in the Treatment of Hormone Refractory Prostate Cancertreatment4completed
NCT00706498
Phase II Study of BI 2536 in Prostate Cancertreatment2completed
NCT06136598
A Study of Opevesostat (MK-5684) in China Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC) (MK-5684-001)treatment1active_not_recruiting
NCT00291005
PhII One Label Non-Comparative Trial in Metastatic Hormone Refractory Prostate Cancer in Combination With Prednisolonetreatment2completed
NCT00489905
Study on Evaluation of Zoledronic Acid to Prevent Bone Loss in Men Receiving Androgen Deprivation Therapy for Prostate CancertreatmentNot Availablecompleted
NCT01918605
Protection of Rectum From High Radiation Doses Using a SpacerNo drug interventionssupportive_careNot Availableterminated
NCT03094897
Clinic Study of 18F-Al-NOTA-MATBBN in Cancer DiagnosticsNo drug interventionsdiagnostic0unknown_status
NCT05228197
Imperial Prostate 6 - Cancer Histology Artificial Intelligence Reliability Study.No drug interventionsNot AvailableNot Availablerecruiting
NCT02526797
Multiparametric MRI in Men With Prostate Cancer Undergoing Active SurveillanceNo drug interventionsNot AvailableNot Availableenrolling_by_invitation
NCT02151097
PRIME - PRostate Imaging for Margin EvaluationNo drug interventionsNot AvailableNot Availablecompleted
NCT00448097
Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomytreatment2terminated
NCT02023697
Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bonetreatment2completed
NCT01086683
Rehabilitation of Cancer Survivors in Denmark: The Effect of a Psychosocial Rehabilitation CourseNo drug interventionssupportive_care2 / 3completed
NCT02647983
Multiparametric MRI for Prostate Cancer Localization and Characterization Using Hyperpolarized Pyruvate (13C) InjectionNo drug interventionsother1withdrawn
NCT02290561
SmartTarget THERAPYNo drug interventionstreatmentNot Availableunknown_status
NCT00564928
A Phase 2 Study to Investigate the Clinical Activity of IPI-504 in Patients With Hormone-resistant Prostate Cancertreatment2completed
NCT01796028
Metformin-Docetaxel Association in Metastatic Hormone-refractory Prostate Cancertreatment2completed
NCT00706628
A Multi-centre 3-arm Randomised Phase II Trial of BIBF 1120 Versus BIBW 2992 Versus Sequential Administration of BIBF 1120 and BIBW 2992 in Patients With Hormone-resistant Prostate Cancertreatment2completed
NCT01288911
A Study of Enzalutamide Versus Bicalutamide in Castrate Men With Metastatic Prostate Cancertreatment2completed
NCT00302471
MK0429 Study in Prostate Cancer Patients With Metastatic Bone Disease (0429-011)No drug interventionstreatment1completed
NCT04964271
Identification of Prostate Cancer Specific Markers in Patients Compared to Healthy ParticipantsNo drug interventionsNot AvailableNot Availablerecruiting
NCT00055471
A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancertreatment2completed
NCT02443571
Retrospective Observational Study Investigating Fluciclovine (18F) (FACBC)No drug interventionsNot AvailableNot Availablecompleted
NCT02043678
Radium-223 Dichloride and Abiraterone Acetate Compared to Placebo and Abiraterone Acetate for Men With Cancer of the Prostate When Medical or Surgical Castration Does Not Work and When the Cancer Has Spread to the Bone, Has Not Been Treated With Chemotherapy and is Causing no or Only Mild Symptomstreatment3completed
NCT00166478
Exisulind Prior to Radical Prostatectomytreatment2completed
NCT04428788
Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment1recruiting
NCT00630188
Shared Decision Making for Prostate Cancer Screening: a Practice-Based Randomized Controlled TrialNo drug interventionspreventionNot Availablecompleted
NCT00692107
Radiotherapy for Prostate Cancer: Conventional Dose Versus High DoseNo drug interventionstreatment3completed
NCT04523207
A Study of Apalutamide (Adjuvant Treatment) and Androgen Deprivation Therapy (ADT) in Participants Who Have Undergone Radical Prostatectomy (RP) for Non-metastatic Prostate Cancer and Who Are at High Risk for Metastasestreatment2completed
NCT00089609
Docetaxel, Thalidomide, Prednisone, and Bevacizumab to Treat Metastatic Prostate Cancertreatment2completed
NCT02788409
Incidence of Second Primary Malignancies in Castration-Resistant Prostate Cancer: An Observational Retrospective Cohort Study in the USNo drug interventionsNot AvailableNot Availablecompleted
NCT00448409
Activity of TroVax® Alone vs. TroVax® Plus GM-CSF in Patients With Prostate Cancertreatment2completed
NCT01641185
Ion Prostate IrradiationNo drug interventionstreatment2completed
NCT03587285
A Pilot Study of Hormonal Therapy Combined With Central Memory T Cells (Tcm) for Patients With Advanced Prostate Cancertreatment1 / 2unknown_status
NCT00519285
Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancertreatment3completed
NCT05264337
Lymphedema After Urologic SurgeryNo drug interventionsNot AvailableNot Availablerecruiting
NCT03987737
Rectal Gas Removal Through Small Catheter Placement Prior to MRI of the ProstateNo drug interventionsdiagnosticNot Availableunknown_status
NCT01550237
Curative Image Guided Radiotherapy for Prostate CancerNo drug interventionstreatmentNot Availableactive_not_recruiting
NCT00822952
Prostate Mechanical Imager (PMI) Clinical Bridging StudyNo drug interventionsNot AvailableNot Availablecompleted
NCT01173952
Quality of Life in Men Undergoing Robotic Assisted Laparoscopic Radical Prostatectomy Versus Radical Retropubic ProstatectomyNo drug interventionsNot AvailableNot Availableunknown_status
NCT01080352
Vitamin C as an Anti-cancer Drugtreatment2completed
NCT03021200
Laser Fluorescence in Cancer Surgical TreatmentNo drug interventionstreatmentNot Availableunknown_status
NCT04425200
Prevalence of HRR-related Genes Mutations and Prognosis in Metastatic Castration Resistant Prostate Cancer (mCRPC) Patients in Real World SettingNo drug interventionsNot AvailableNot Availablecompleted
NCT02230059
Study to Assess the Treatment Patterns in Metastatic Castration-Resistance Prostate Cancer (mCRPC)No drug interventionsNot AvailableNot Availablecompleted
NCT04557059
A Study of Adding Apalutamide to Radiotherapy and LHRH Agonist in High-Risk Patients With Hormone-Sensitive Prostate Cancertreatment3active_not_recruiting
NCT03479359
Learning Curve of Digital Rectal Examination for Prostate Cancer Among InternshipNo drug interventionsNot AvailableNot Availableunknown_status
NCT01024959
Clinical Evaluation of the PROGENSA(Registered Trademark) Prostate Cancer Gene 3 (PCA3) Assay in Men With a Previous Negative Biopsy ResultNo drug interventionsdiagnosticNot Availablecompleted
NCT01723475
First-in-man Dose Escalation Study of BAY2010112 in Patients With Prostate CancerNo drug interventionstreatment1completed
NCT04024475
Prostate Cancer BiobankNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT03824275
18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancerdiagnostic2 / 3active_not_recruiting
NCT02963675
Incidence of Second Primary Malignancies in Prostate Cancer Patients With Bone Metastases - an Observational Retrospective Cohort Study in SwedenNo drug interventionsNot AvailableNot Availablecompleted
NCT05834270
Single Dose Versus Double Dose Tamsulosin in Management of Moderate and Severe LUTS Due to BPHtreatmentNot Availablecompleted
NCT04644770
A Study of JNJ-69086420, an Actinium-225-Labeled Antibody Targeting Human Kallikrein-2 (hK2) for Advanced Prostate Cancertreatment1recruiting
NCT00188799
Xray Volume Imaging (Cone Beam CT) - Prostate CancerNo drug interventionstreatment2completed
NCT03261999
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate (LMIS 25 mg) in Subjects With Prostate Cancertreatment3completed
NCT04638049
Intestinal Microbiota in Prostate Cancer Patients as a Biomarker for Radiation-INduced Toxicity (IMPRINT)No drug interventionsbasic_scienceNot Availablecompleted
NCT02260349
Interest of Indocyanine Green in Neoplastic Prostatic Tissuediagnostic3withdrawn
NCT00744549
Study of Antioxidants on MRI Detectable Early Stage Prostate Cancer Among Men on Active SurveillanceNo drug interventionstreatment2completed
NCT01577836
Medico-economic Comparison of Robot-assisted Radical Prostatectomy Versus Radical Prostatectomy Via LaparotomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02854436
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomaliestreatment2completed
NCT01206036
CESAR Study in Prostate Cancer With Temsirolimus Added to Standard Docetaxel Therapy (CEPTAS)treatment1 / 2completed
NCT04452136
Expanded Access Protocol of 68Ga PSMA 11 PET Imaging of Prostate CancerNot AvailableNot Availableapproved_for_marketing
NCT02508636
Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate Cancertreatment2terminated
NCT01759836
Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancerprevention2completed
NCT00035113
EPO906 Therapy in Patients With Prostate Cancertreatment2completed
NCT01441713
Treatment Frequency and Satisfaction in Patients With Advanced Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00188513
Intensity Modulated Radiation Therapy - Prostate CancerNo drug interventionstreatment1 / 2completed
NCT02004418
A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate GlandNo drug interventionstreatment1 / 2completed
NCT06151418
A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed ForcesNot AvailableNot Availableactive_not_recruiting
NCT02182219
Oral Treatment With BIBF 1120 Together With Docetaxel and Prednisone in Patients With Hormone Refractory Prostate Cancertreatment1completed
NCT03805919
Men at High Genetic Risk for Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT03834519
Study of Pembrolizumab (MK-3475) Plus Olaparib Versus Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-7339-010/KEYLYNK-010)treatment3completed
NCT00080041
Study of Motexafin Gadolinium and Docetaxel for Advanced Solid Tumorstreatment1completed
NCT04898634
A Study of JNJ-78278343, a T-Cell-Redirecting Agent Targeting Human Kallikrein 2 (KLK2), for Advanced Prostate CancerNo drug interventionstreatment1recruiting
NCT00250224
Prostate Localization During Radiotherapy Using a Ni-Ti Stent and Electronic Portal Imaging - Protocol IINo drug interventionstreatment1completed
NCT00253916
Exercise in Men Receiving Radiation Therapy for Prostate Cancer.No drug interventionspreventionNot Availablecompleted
NCT00568516
Phase II Study of ASP3550 in Patients With Prostate Cancertreatment2completed
NCT03237416
Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteersother1completed
NCT01464216
MRI for Assessment of Hypoxia-Induced Prostate Cancer AggressivenessNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT06072196
A Study to Learn About Novel Hormonal Therapies in People With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)Not AvailableNot Availablecompleted
NCT00748358
An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancertreatment2completed
NCT02123758
A Study of JNJ-56021927 (ARN-509) and Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancertreatment1active_not_recruiting
NCT03241758
Vascular Changes Of Patients Undergoing Laparoscopic Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT01995058
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancertreatment2terminated
NCT05918263
Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE TrialNo drug interventionssupportive_careNot Availablerecruiting
NCT00579163
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial CancersNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00040586
Phase II Trial of Monoclonal Antibody (J591) in Combination With Low-Dose Subcutaneous Interleukin-2treatment2completed
NCT00230386
Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate CarcinomaNo drug interventionstreatment1 / 2completed
NCT03879486
Infectious Outcomes of Povidone-iodine Rectal Cleansing Plus Formalin Disinfection of Needle During Prostate BiopsyNo drug interventionspreventionNot Availablecompleted
NCT00546039
Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancerbasic_science2unknown_status
NCT00406939
Vector Delivery of the IL-12 Gene in Men With Prostate CancerNo drug interventionstreatment1completed
NCT00705822
Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancertreatment3terminated
NCT00177125
Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRPNo drug interventionsprevention3completed
NCT01653925
Molecular Mechanisms of Dutasteride and Dietary Interventions to Prevent Prostate Cancer and Reduce Its ProgressionpreventionNot Availableactive_not_recruiting
NCT00917748
Study With Modafinil in Patients Treated With Docetaxel-Based Chemotherapy for Metastatic Breast or Prostate Cancer (MOTIF)treatment3completed
NCT01095848
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate CancerNo drug interventionstreatment1completed
NCT00930748
Evaluation of MRI for Prostate CancerNo drug interventionsNot AvailableNot Availableterminated
NCT00482157
Calcitriol or Placebo in Men for Prostate Cancer Active SurveillancetreatmentNot Availablewithdrawn
NCT04720157
An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPCtreatment3active_not_recruiting
NCT02475057
Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonistsother4completed
NCT02924766
A Safety and Pharmacokinetics Study of Niraparib Plus an Androgen Receptor-Targeted Therapy in Men With Metastatic Castration-Resistant Prostate Cancer (BEDIVERE)treatment1completed
NCT05288166
A Study of Abemaciclib (LY2835219) With Abiraterone in Men With Prostate Cancer That Has Spread to Other Parts of the Body and is Expected to Respond to Hormonal Treatment (Metastatic Hormone-Sensitive Prostate Cancer)treatment3active_not_recruiting
NCT06253065
Prospective Validation of Pathology-based Artificial Intelligence Diagnostic Model for Lymph Node Metastasis in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00040365
Amifostine to Protect the Rectum During External Beam Radiotherapy for Prostate Cancersupportive_care2completed
NCT01423474
Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment TimeNo drug interventionstreatmentNot Availablecompleted
NCT05714774
Evaluation of Different Methods of Ultrasound Image Analysis for Real-time Monitoring of HIFU Prostate Cancer TreatmentNo drug interventionstreatmentNot Availablerecruiting
NCT04839120
PK, PD, Tolerability and Safety of MDPK67b in Healthy VolunteersNo drug interventionstreatment1completed
NCT00001382
A Phase I Study of Recombinant Vaccinia Virus That Expresses Prostate Specific Antigen in Adult Patients With Adenocarcinoma of the ProstateNo drug interventionstreatment1completed
NCT02854982
Impact on Quality of Life 3 Years After Diagnosis of Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00378482
A Rollover Study for Patients Who Received Tremelimumab in Other Protocols, to Allow the Patients Access to Tremelimumab Until This Agent Becomes Commercially Available or Development is Discontinued.treatment2completed
NCT01545882
A Phase II Study of Degarelix in the Management of Non-Metastatic Hormone-Refractory Prostate Cancertreatment2terminated
NCT02364531
A Canadian Observational Study in Metastatic Cancer of the Prostate: A Study of ZYTIGA Use in the Community Urology SettingNo drug interventionsNot AvailableNot Availablecompleted
NCT03501173
A Study of Participants With Advanced Prostate Cancer in CanadaNo drug interventionsNot AvailableNot Availablecompleted
NCT03390127
Effect of PEEP on Arterial Oxygen Partial Pressure in Elderly Patients With Lithotomy Position Using LMA Supreme™No drug interventionssupportive_careNot Availablecompleted
NCT04907227
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)-China Extensiontreatment3terminated
NCT02692976
Natural Dendritic Cells for Immunotherapy of Chemo-naive Metastatic Castration-resistant Prostate Cancer PatientsNo drug interventionstreatment2completed
NCT03101176
Multiparametric Ultrasound Imaging in Prostate CancerdiagnosticNot Availableunknown_status
NCT05022160
Preventing Catheter Related Bladder Discomfort (CRBD) With Bilateral Pudendal Nerve BlockNo drug interventionstreatment0unknown_status
NCT03315260
Treatment Satisfaction With Ra-223 in JapanNot AvailableNot Availablecompleted
NCT01683994
Cabozantinib Plus Docetaxel and Prednisone for Advanced Prostate Cancertreatment1 / 2completed
NCT04085991
Two TraCer PositROn EmiSSion Tomography ComBination for Efficacy EstimatiOn of Prostate Specific Membrane Antigen Radioligand Therapy in Patients With Metastatic Prostate CancerNo drug interventionstreatment2terminated
NCT05123391
Randomized Pilot Study of Radiosurgery for the Treatment of Non-metastatic Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT05670691
a Study of Combined mpMRI and PSMA PET/CT for Highly Suspicious Patients Performing Radical Prostatectomy Without BiopsyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT02772562
Adjuvant PROSTVAC-V/F in Subjects at High Risk for Relapse After Radical ProstatectomyNo drug interventionstreatment2completed
NCT01976962
Functional MR-guided Stereotactic Body Radiation Therapy of Prostate CancerNo drug interventionstreatmentNot Availableterminated
NCT06379880
Impact on Quality of Life and Health of the CONTINUUM+ CONNECT Remote Monitoring SolutionNo drug interventionspreventionNot Availablerecruiting
NCT05068180
Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly PatientsNo drug interventionsprevention4unknown_status
NCT00185029
MR-Lymphography and Lymph Node Staging in Prostate CancerNo drug interventionsdiagnostic4unknown_status
NCT02053389
Testing Decision Aids About Early Stage Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT00152789
Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate BiopsyNo drug interventionsdiagnostic2completed
NCT01685489
A Phase 1b Dose Escalation Trial of PSK®/Placebo With Docetaxel to Treat Metastatic Castration-resistant Prostate Cancertreatment1withdrawn
NCT01647789
A Study of Oral CFG920 in Patients With Castration Resistant Prostate Cancertreatment1terminated
NCT01711892
Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation TherapyNo drug interventionssupportive_careNot Availablecompleted
NCT03767244
A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomytreatment3active_not_recruiting
NCT02446444
Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancertreatment3active_not_recruiting
NCT00551044
Bicalutamide Monotherapy Has Significant Quality of Life Benefits for Men With Advanced Prostate CancertreatmentNot Availablecompleted
NCT04839367
Positron Emission Tomography (PET) Imaging of Participants With Confirmed Prostate Cancer Using 64Cu-SAR-bisPSMA (PROPELLER)No drug interventionsdiagnostic1completed
NCT05335967
Effectiveness Evaluation of a Self-management Program for Prostate Cancer SurvivorsNo drug interventionshealth_services_researchNot Availablerecruiting
NCT02344667
Feasibility Study of Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer: Cyberknife vs. VMATNo drug interventionstreatment2unknown_status
NCT05441501
A Study of JNJ-80038114 in Participants With Advanced Stage Prostate CancerNo drug interventionstreatment1completed
NCT00106301
Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study With FK228treatment2completed
NCT02905201
A Prospective Compliance Registry for Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)No drug interventionsNot AvailableNot Availablewithdrawn
NCT01834001
Imaging Studies to Check the Local Response of Prostate Cancer to Radiation TherapyNo drug interventionsNot AvailableNot Availablerecruiting
NCT01132404
Study in Men With Prostate Cancer to Assess the Safety, Pharmacokinetics and Testosterone-Lowering Efficacy of TAK-448treatment1 / 2terminated
NCT01821404
Atorvastatin Before Prostatectomy and Prostate Cancerprevention2completed
NCT01981668
The JET Study: a Phase I Trial of Cabazitaxel, Radiotherapy and Long-term Androgen Deprivationtreatment1withdrawn
NCT02771769
Analysis of Cell-free DNA (cfDNA) in Men With Elevated PSA LevelsNo drug interventionsNot AvailableNot Availableterminated
NCT00906269
Can Hyperbaric Oxygen Improve Erectile Function Following Surgery for Prostate Cancertreatment4unknown_status
NCT02064946
High-dose Vitamin D Supplementation for ADT-induced Side EffectsNo drug interventionssupportive_careNot Availablecompleted
NCT02899312
PSMA PET/CT for Assessment of Recurrent Prostate CancerNot AvailableNot Availablerecruiting
NCT01357512
Evaluation of Diagnostic Value of 3-T Magnetic Resonance Imaging (MRI) in Suspected Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT04298112
PSMA-PET and MRI for Detection of Recurrent Prostate Cancer After Radical TreatmentNo drug interventionsNot AvailableNot Availablecompleted
NCT00853710
Test Semiquantitative Prostate Specific Antigen (PSA)No drug interventionsdiagnosticNot Availablecompleted
NCT00268710
Docetaxel in Hormone Refractory Prostate Cancer (HRPC)[Weekly or 3weekly TAX + Prednisone in HRPC]treatment2completed
NCT00064610
Phase I/II Dose Escalation Study of VELCADE® and Docetaxel in Patients With Advanced Androgen-Independent Prostate Cancertreatment1 / 2completed
NCT02631681
Supervised Group Based Exercise for Men With Prostate Cancer on Androgen Deprivation TherapyNo drug interventionstreatmentNot Availablecompleted
NCT00313781
Study of CP-751,871 in Combination With Docetaxel and Prednisone in Patients With Hormone Insensitive Prostate Cancer (HRPC)treatment2completed
NCT00521781
Study of Abraxane Plus Hormonal Therapy as Initial Treatment of Unresectable or Metastatic Prostate Cancertreatment2terminated
NCT02600481
Impacts of Different Pressure Pneumoperitoneum on Myocardial and Pulmonary Injuries After Robot-assisted SurgeryNo drug interventionstreatmentNot Availableunknown_status
NCT00121095
Study of Samarium Sm-153 Lexidronam Combined With Docetaxel for Patients With Prostate Cancertreatment1 / 2unknown_status
NCT03677414
Analysis of Androgene Receptors Axis and DNA Damage Repair Genes in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT02156414
Lymph Node Involvement Using Extended Pelvic Lymphadenectomy in Clinically Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT00900614
Safety Study of APR-246 in Patients With Refractory Hematologic Cancer or Prostate Cancertreatment1completed
NCT02506114
Neoadjuvant PROSTVAC-VF With or Without Ipilimumab for Prostate Cancertreatment2terminated
NCT05413850
Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injectiontreatment1 / 2recruiting
NCT00676650
Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapytreatment3terminated
NCT01681823
Effect of Modified Citrus Pectin on PSA Kinetics in Biochemical Relapsed PC With Serial Increases in PSANo drug interventionstreatment2completed
NCT00450008
Safety and Efficacy Study of GM-CSF, Thalidomide Plus Docetaxel in Prostate Cancertreatment2terminated
NCT02813408
A Study to Investigate the Impact of Abiraterone Acetate and Enzalutamide on Health-related Quality of Life, Participant-Reported Outcomes, and Medical Resource Use in Metastatic Castration-resistant Prostate Cancer ParticipantsNo drug interventionsNot AvailableNot Availablecompleted
NCT00976508
Figitumumab Combined With Pegvisomant For Advanced Solid Tumorstreatment1terminated
NCT02702908
Second Primary Cancers in Patients With Castration Resistant Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01522443
Study of Cabozantinib (XL184) Versus Mitoxantrone Plus Prednisone in Men With Previously Treated Symptomatic Castration-resistant Prostate Cancertreatment3terminated
NCT05872503
Study of Rates of Prostate Cancer Diagnosis in Men of African Ancestry Using MRI and MRI Guided BiopsyNo drug interventionsNot AvailableNot Availablerecruiting
NCT02076503
Pre-operative PET-MR of High Risk Prostate Cancer Patients for Assessment of Cancer Aggressiveness and Lymph Node StatusNo drug interventionsdiagnosticNot Availablecompleted
NCT02621190
Cabazitaxel in mCRPC Patients With AR-V7 Positive CTCsdiagnostic2withdrawn
NCT00638690
Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapytreatment3completed
NCT02950064
A Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsNo drug interventionstreatment1unknown_status
NCT02138721
Local Treatment With RP for Newly-diagnosed mPCaNo drug interventionstreatmentNot Availablerecruiting
NCT00403221
Phase I - Pre-Radical Prostatectomy RTVP-1 Gene Therapy for Prostate CancerNo drug interventionstreatment1completed
NCT02526602
Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial.No drug interventionstreatmentNot Availablecompleted
NCT02043184
Improving Adherence to Oral Cancer Agents and Self Care of Symptoms Using an IVRNo drug interventionssupportive_careNot Availablecompleted
NCT00160979
Transrectal Tumour Oxygen - US ArmyNo drug interventionsdiagnostic2completed
NCT00417079
XRP6258 Plus Prednisone Compared to Mitoxantrone Plus Prednisone in Hormone Refractory Metastatic Prostate Cancertreatment3completed
NCT00031187
Study of SGN-15, Antibody-Drug Conjugate, to Treat Hormone Refractory Prostate Cancertreatment2completed
NCT00383487
A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancertreatment2terminated
NCT00050687
Safety and Pharmacokinetics of Orally Administered Gallium Maltolate in Various Refractory Malignanciestreatment1 / 2terminated
NCT04577833
A Study of Comparative Formulations of Niraparib and Abiraterone Acetate (AA) in Men With Prostate Cancerother1active_not_recruiting
NCT00056654
Study of a 6-Month Sustained-Release Formulation of Leuprolide Acetate in Prostate CancertreatmentNot Availablecompleted
NCT02560051
Hormone Therapy Plus Chemotherapy as Initial Treatment for Local Failures or Advanced Prostate Cancertreatment2terminated
NCT01076751
Observational Registry of Treatment Patterns in Castrate-resistant Prostate Cancer (CRPC) PatientsNo drug interventionsNot AvailableNot Availableterminated
NCT01377753
MR Image Guided Therapy in Prostate CancerNo drug interventionstreatment2completed
NCT06209853
Correlation Between PSA Levels and F-18 PSMA PET/CT Findings in Prostate Cancer PatientNo drug interventionsNot AvailableNot Availablerecruiting
NCT02102477
Surgery Versus Radiotherapy for Locally Advanced Prostate CancerNo drug interventionstreatmentNot Availablerecruiting
NCT00001377
Familial Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT05851547
Dose Escalation For INtraprostatic LEsionstreatment2recruiting
NCT04295447
Adjuvant Apalutamide in Subjects With High-risk Localized or Locally Advanced Prostate Cancer After Radical Prostatectomytreatment2active_not_recruiting
NCT00476645
Fulvestrant in Hormone Refractory Prostate Cancertreatment2completed
NCT03436745
The Effects of Castration on the Pharmacokinetics of Zolpidem After Single Dose Administration In Men With Prostate Cancer Undergoing Androgen Deprivation Therapy Compared to Normal Healthy Femalesbasic_science1completed
NCT03533998
Biomarkers in Prostate Cancer Treated With SRP Following Failure of FATNo drug interventionsNot AvailableNot Availableunknown_status
NCT06547398
Prostate Adaptive Radiation TherapyNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT04101305
Measurement of Circulating Tumor Cells in Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT01020305
Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancertreatment1 / 2terminated
NCT02446405
Enzalutamide in First Line Androgen Deprivation Therapy for Metastatic Prostate Cancertreatment3active_not_recruiting
NCT00744497
Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-resistant Prostate Cancertreatment3completed
NCT01450683
Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapytreatment2terminated
NCT00060528
Sequential Vaccinations in Prostate Cancer PatientsNo drug interventionstreatment1 / 2completed
NCT04689828
177Lu-PSMA-617 vs. Androgen Receptor-directed Therapy in the Treatment of Progressive Metastatic Castrate Resistant Prostate Cancertreatment3active_not_recruiting
NCT04033328
Study of ORIC-101 in Combination With Enzalutamidetreatment1terminated
NCT03834493
Study of Pembrolizumab (MK-3475) Plus Enzalutamide Versus Placebo Plus Enzalutamide in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-641/KEYNOTE-641)treatment3active_not_recruiting
NCT00039793
Massage Therapy for Cancer-Related FatigueNo drug interventionstreatment2completed
NCT00861471
Docetaxel (Taxotere) and Imatinib Mesylate (Gleevec) in Hormone Refractory Prostate Cancertreatment1 / 2terminated
NCT02284971
Pilot Study of SBRT and CDX-1127 in Prostate Cancertreatment1terminated
NCT02718378
Evaluation of Safety and Efficacy of Estetrol in Healthy Menbasic_science1completed
NCT04628988
A Study of CC-90011 and Comparators in Participants With Prostate Cancertreatment1completed
NCT01802307
Focal Therapy for Prostate CancerNo drug interventionstreatment2withdrawn
NCT02453009
Addition of Enzalutamide to First Line Docetaxel for Castration Resistant Prostate Cancertreatment2completed
NCT04461509
High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomyother2active_not_recruiting
NCT00672009
A Study of Ixabepilone Before Surgery for High-Risk Localized Prostate Cancertreatment2terminated
NCT00036556
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate Cancertreatment3completed
NCT00452556
The ELDORADO (Eligard®, Docetaxel and Radiotherapy) Studytreatment2unknown_status
NCT06282185
SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapyNo drug interventionstreatmentNot Availablesuspended
NCT02616185
A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)treatment1terminated
NCT02234115
Safety, Efficacy, and Pharmacokinetic Behavior of Leuprolide Mesylate in Subjects With Advanced Prostate Carcinomatreatment3completed
NCT03421015
Genetic Analysis of Prostate Cancer to Identify Predictive Markers of Disease Relapse or Metastatic EvolutionNo drug interventionsNot AvailableNot Availableunknown_status
NCT00070837
MLN2704 in Subjects With Metastatic Androgen-Independent Prostate Cancertreatment1 / 2completed
NCT05902637
The Efficacy Of Mapping For Cognitive Prostate BiopsyNo drug interventionsdiagnosticNot Availablerecruiting
NCT02014337
Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumorstreatment1completed
NCT00667537
PK in Pts With HRPC & Skeletal Metastesbasic_science1completed
NCT03553732
An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net HospitalNo drug interventionsNot AvailableNot Availableterminated
NCT03007732
Pembrolizumab +/- SD-101 in Hormone-Naïve Oligometastatic Prostate Cancer With RT and iADTtreatment2active_not_recruiting
NCT02034552
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC)treatment2completed
NCT02338700
Safety and Efficacy Study of Mix Vaccine in Prostate Carcinoma PatientNo drug interventionstreatment1 / 2completed
NCT02584400
Tumor Hypoxia With HX4 PET in Several DiseasesNo drug interventionsdiagnostic2terminated
NCT05765500
RecoverPC: Relugolix vs GnRH Agonist in Quality of Lifetreatment2recruiting
NCT00048659
YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone TherapyNo drug interventionstreatment2terminated
NCT04983459
PSMA PET/CT for Biochemical Recurrence Detection in Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT03648359
Multiparametric MRI in Men With Prostate Cancer Enrolled in Active SurveillanceNo drug interventionsdiagnosticNot Availableenrolling_by_invitation
NCT01991275
Intrathecal Morphine in Robot-assisted ProstatectomytreatmentNot Availablecompleted
NCT04093375
Radical Prostatectomy Versus Radical Radiotherapy for Locally Advanced Prostate CancerNo drug interventionstreatmentNot Availablenot_yet_recruiting
NCT01618370
Radium(223) Dichloride (Alpharadin) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastasestreatment3completed
NCT01810770
Radium-223 Dichloride Asian Population Study in the Treatment of CRPC Patients With Bone Metastasistreatment3completed
NCT00040170
Vaccine Study of MVA-MUC1-IL2 in Patients With Prostate Cancertreatment2terminated
NCT03523442
A Study of Androgen Receptor (AR) Antagonist Apalutamide in Chinese Participants With Metastatic Castration-Resistant Prostate Cancertreatment1active_not_recruiting
NCT04736199
Darolutamide in Addition to ADT Versus ADT in Metastatic Hormone-sensitive Prostate Cancertreatment3active_not_recruiting
NCT01913106
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancertreatment1 / 2recruiting
NCT03834506
Study of Pembrolizumab (MK-3475) Plus Docetaxel Versus Placebo Plus Docetaxel in Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-3475-921/KEYNOTE-921)treatment3completed
NCT04836949
Verification of Shear Wave Elastography for DEtection of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT06104449
A Study of Opevesostat (MK-568)4 in Japanese Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-005)treatment1active_not_recruiting
NCT02430649
Irreversible Electroporation(IRE) For Unresectable Prostatic NeoplasmsNo drug interventionstreatmentNot Availablewithdrawn
NCT05022849
A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsNo drug interventionsother1active_not_recruiting
NCT02381236
G-202 in the Neoadjuvant Setting Followed by Radical Prostatectomy in Patients With Prostate Cancertreatment2completed
NCT00381836
Effect of Darbepoetin Alfa (Aranesp®) on Anemia in Patients With Advanced Hormone Independent Prostate Cancersupportive_care2 / 3terminated
NCT00446836
Efficacy and Safety Study of Xyotax to Treat Prostate Cancertreatment2completed
NCT00137436
Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancertreatment1 / 2completed
NCT02257736
An Efficacy and Safety Study of Apalutamide (JNJ-56021927) in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC)treatment3active_not_recruiting
NCT05150236
EVOLUTION: 177Lu-PSMA Therapy Versus 177Lu-PSMA in Combination With Ipilimumab and Nivolumab for Men With mCRPCtreatment2active_not_recruiting
NCT00878436
Safety and Efficacy Studies of Panobinostat and Bicalutamide in Patients With Recurrent Prostate Cancer After Castrationtreatment1 / 2completed
NCT05266313
Contributions of a Paramedical Approach in the Prevention and Treatment of Side Effects Associated With Radical ProstatectomyNo drug interventionssupportive_careNot Availableactive_not_recruiting
NCT04838613
Study of Diagnostic Performance of [18F]CTT1057 in BCRdiagnostic3completed
NCT02668718
Adjuvant Radiation Therapy vs. Watchful Waiting Following Radical Prostatectomy in High Risk Prostate CancerNo drug interventionstreatment3unknown_status
NCT03365518
Innovations in the Treatment of Sexual Health Post Prostate Cancer Treatment: Comparing Mindfulness vs. CBTNo drug interventionssupportive_careNot Availablecompleted
NCT00177619
Prevention of Osteoporosis in Men With Prostate Cancer on Androgen Deprivation Therapy (POP Study)treatment3completed
NCT00152919
Mobicox: Study of Meloxicam to Reduce Prostate Swelling in Permanent Seed Prostate Brachytherapytreatment3completed
NCT06242119
Clinical Application of the J-PET Scanner PrototypeNo drug interventionsNot AvailableNot Availablerecruiting
NCT01296217
Sentinel Lymph Node Detection in Prostate Surgery by LaparoscopyNo drug interventionsNot AvailableNot Availablecompleted
NCT02125617
Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate CancerNot AvailableNot Availableterminated
NCT01857817
Efficacy and Safety Study of Etodolac and Propranolol in Patients With Clinically Progressive Prostate Cancertreatment2terminated
NCT00514917
A Study of Androgen Deprivation With Leuprolide, +/- Docetaxel for Clinically Asymptomatic Prostate Cancer Participants With a Rising Prostate Specific Antigen (PSA)treatment3terminated
NCT02744534
Targeted Fusion Biopsy of the ProstateNo drug interventionsdiagnostic2completed
NCT00182624
Magnetic Resonance Imaging to Evaluate Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT01962324
Dose Escalation With SIB to Intraprostatic/Lymphatic GTV in High Risk Prostate CancerNo drug interventionstreatmentNot Availablecompleted
NCT02943824
Machine-learning Optimization for Prostate Brachytherapy PlanningNo drug interventionsotherNot Availablecompleted
NCT03481816
Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccinestreatment1completed
NCT03827616
Moderately Hypofractionated Radiotherapy for Prostate Cancer.No drug interventionstreatment2enrolling_by_invitation
NCT02531516
An Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLAStreatment3active_not_recruiting
NCT02631616
Treatment With Sandostatin in Patients With Castrate Resistance Prostate Cancer Showing Uptake of 68Ga-DOTATETtreatment1unknown_status
NCT02651896
Hypofractionated Intensity Modulated and Image Guided Radiotherapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availableunknown_status
NCT00061035
Evaluation of Transgenic Lymphocyte Immunization Vaccine in Subjects With Prostate AdenocarcinomaNo drug interventionstreatment1completed
NCT05506735
The Role of the Seven Sweeps in the Prevention of the Prostate Cancer Among Those With a Positive Family HistoryNo drug interventionsNot AvailableNot Availablecompleted
NCT03565835
Abiraterone With Discontinuation of Gonadotropin-Releasing Hormone Analogues in Metastatic Prostate Cancertreatment2unknown_status
NCT06433063
Effect of Hypoxia on FMISO PET to Response to Lu-177 PSMA TreatmentNo drug interventionsdiagnosticNot Availablerecruiting
NCT02182063
A Study With BIBF 1120 in Patients With Hormone Refractory Prostate Cancertreatment2completed
NCT01955863
Outpatient Radical Prostatectomy - Surgical and Anesthetic ConsiderationsNo drug interventionstreatmentNot Availablecompleted
NCT00188786
Cone Beam CT for Daily Image Guidance - Prostate CancerNo drug interventionstreatment2completed
NCT06554639
A Drug-Drug Interaction Study of Diltiazem and MK-5684 in Healthy Adult Male Participants (MK-5684-011)treatment1active_not_recruiting
NCT00436839
Taxotere Prostate Cancer New Indication Registration Trial in Chinatreatment3completed
NCT00817739
Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,ctreatment2completed
NCT00120939
Study of Motexafin Gadolinium and Docetaxel for Advanced Cancertreatment1completed
NCT00032825
Ketoconazole Plus Docetaxel to Treat Prostate Cancertreatment1completed
NCT02391025
Gallium-68 Citrate PET Used in Prostate Cancerdiagnostic0completed
NCT02233725
MRI / Ultrasound Fusion With Contrast-Enhanced Ultrasound GuidanceNo drug interventionsdiagnostic1unknown_status
NCT02079025
Multi-Center Trial of High-resolution Transrectal Ultrasound Versus Standard Low-resolution Transrectal Ultrasound for the Identification of Clinically Significant Prostate CancerNo drug interventionsotherNot Availablecompleted
NCT06056830
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical ProstatectomyNo drug interventionsdiagnostic3recruiting
NCT01816048
NaF Positron Emission Tomography/Computed Tomography (PET/CT)Imaging to Assess Treatment Responsiveness to TAK-700 in Patients With Castrate Resistant Prostate Cancer (CRPC) With Bone Metastasistreatment2terminated
NCT02672657
Determinants of Quality Of Life in AGEd Cancer PatientsNo drug interventionsNot AvailableNot Availableunknown_status
NCT01198457
Study to Investigate Adherence of Patients to Clodronate (Bonefos) TreatmentNot AvailableNot Availablecompleted
NCT03119857
Early Rising PSA Endocrine Treatment Versus Chemo-endocrine Therapy- SPCG14treatment3unknown_status
NCT04838626
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detectiondiagnostic2 / 3completed
NCT04833426
Impact of Peri-operative tEstosterone Levels on oNcological and Functional Outcomes in RadiCal prostatEctomytreatment3recruiting
NCT00110526
Gene Therapy for Prostate Cancer That Returns After Radiation TherapyNo drug interventionstreatment1withdrawn
NCT01443026
The Effects of Lycopene on High Risk Prostatic Tissueprevention2completed
NCT00166426
Exisulind Versus Placebo After Surgical Removal of the Prostateprevention2completed
NCT02217566
Study of Abiraterone Acetate in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC), Chemo-Naive, Who Received a Prior Diethylstilbestrol Therapytreatment2completed
NCT03600766
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Studytreatment2unknown_status
NCT00127465
Investigating the Impact of Tailored Reports on Anxiety Amongst Cancer Patients and Their ConfidantsNo drug interventionsNot Available1 / 2completed
NCT00401765
A Study of CNTO 328 in Patients With Metastatic Hormone-Refractory Prostate Cancertreatment1completed
NCT01420965
Sipuleucel-T, CT-011, and Cyclophosphamide for Advanced Prostate Cancertreatment2terminated
NCT00756665
Prostate Active Surveillance StudyNo drug interventionsNot AvailableNot Availablerecruiting
NCT00521274
Study of Trovax® Plus Docetaxel Versus Docetaxel Alone in Patients With Progressive Hormone Refractory Prostate Cancertreatment2terminated
NCT02831920
CEUS Targeted Biopsies Compared to mpMRI Targeted and Systematic Biopsies for the Detection of Prostate CancerNo drug interventionsdiagnosticNot Availableunknown_status
NCT00573820
Far Infrared Radiation Treatment for Prostate CancerNo drug interventionstreatment1unknown_status
NCT02712320
Open-Label Safety Extension Study in Patients Who Have Previously Participated and Have Benefited From LMIS 50 mgNo drug interventionstreatment3completed
NCT02245282
Contrast Enhanced MRI of the ProstateNo drug interventionsNot AvailableNot Availablecompleted
NCT01446731
Dendritic Cell Vaccination and Docetaxel for Patients With Prostate Cancertreatment2completed
NCT04652973
Evaluation of Atherosclerotic Plaques in Abdominal CT StudiesNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT00447473
Trial of GM-CSF Given in Combination With Ketoconazole and Mitoxantrone in Patients With Progressive Prostate Cancertreatment2terminated
NCT05295927
A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)treatment1terminated
NCT01605227
Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100treatment3completed
NCT02668276
Engaging Newly Diagnosed Men About Cancer Treatment OptionsNo drug interventionsotherNot Availablecompleted
NCT02677376
Imaging Biomarkers to Validate Response in Enzalutamide-Treated mCRPCNo drug interventionsNot AvailableNot Availablecompleted
NCT01347476
Aggressive Prostate Cancers in Elderly PatientsNo drug interventionsNot AvailableNot Availablecompleted
NCT05633160
64Cu-SAR-BBN and 67CU SAR-BBN for Identification and Treatment of Gastrin Releasing Peptide Receptor (GRPR)-Expressing Metastatic Castrate Resistant Prostate Cancer in Patients Who Are Ineligible for Therapy With 177Lu-PSMA-617 (COMBAT)No drug interventionstreatment1 / 2recruiting
NCT04521894
The Application Value of 18F-prostate-specific Membrane Antigen PET/CT in Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT00235794
An Open Label Exploratory Study in Newly Diagnosed Prostate Cancer PatientspreventionNot Availablecompleted
NCT00962494
Cancer: Thriving and Surviving Online Workshop and Study for Cancer SurvivorsNo drug interventionssupportive_care2completed
NCT02869594
Institut Paoli Calmettes Prostate Cancer DatabaseNo drug interventionsNot AvailableNot Availablerecruiting
NCT02563691
Stereotactic Radiotherapy for Oligometastatic Prostate CancerNo drug interventionstreatment1 / 2unknown_status
NCT01717391
[F-18] Fluorothymidine PET/CT Imaging for Pelvic CancersNo drug interventionstreatment2completed
NCT00038662
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failuretreatment2completed
NCT03526562
Exercise Prescription Dose for Castration Resistance Prostate Cancer PatientsNo drug interventionstreatmentNot Availablecompleted
NCT00283062
Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomytreatment3completed
NCT01516762
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone MetastasesNot AvailableNot Availableno_longer_available
NCT01640262
Evaluation of Modern MRI in the Diagnosis of Prostate Cancer in a Danish SetupNo drug interventionsNot AvailableNot Availablecompleted
NCT01023529
Symptoms and Quality of Life (QoL) After Palliative Pelvic Radiation of Prostate and Rectal CancersNo drug interventionsNot AvailableNot Availablecompleted
NCT01576029
Continued Treatment With Docetaxel Versus Switch to Cabazitaxel After Minor Prostate Specific Antigen Response to Docetaxel in Patients With Castration-Resistant Metastatic Prostate Cancertreatment2completed
NCT04430192
Dosimetry, Safety and Potential Benefit of 177Lu-PSMA-617 Prior to Prostatectomytreatment1 / 2active_not_recruiting
NCT00844792
Study of Antioxidants on Prostate Tumors in Men Undergoing Radical Prostatectomy for Prostate CancerNo drug interventionstreatment2completed
NCT00075192
CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancertreatment1 / 2completed
NCT00007540
Study of Prostate Cancer in Black and White U.S. VeteransNo drug interventionsNot AvailableNot Availablecompleted
NCT00446901
Selenium and Prostate Cancer: Clinical Trial on Availability to Prostate Tissue and Effects on Gene ExpressionNo drug interventionspreventionNot Availablecompleted
NCT04967001
68Ga-PSMA PET in the Prostate CancerNo drug interventionsdiagnosticNot Availablerecruiting
NCT05958004
The Application Value of Prostate Specific Membrane Antigen PET/CT in Biopsy Free of PSA Grey Area Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04017104
Dynamic Whole Body Positron Emission Tomography/Computed Tomography ImagingNo drug interventionsNot AvailableNot Availableunknown_status
NCT02919904
Feasibility Study for the Assessment of Sleep Quality in Men With Prostate Cancer Starting ADTNo drug interventionsNot AvailableNot Availablecompleted
NCT05941104
The Effect of Frailty on Blood Biology Indicators, Quality of Life and Survival of Patients With Radical ProstatectomyNo drug interventionsNot AvailableNot Availablenot_yet_recruiting
NCT01946204
A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancertreatment3active_not_recruiting
NCT01335204
Ph Ib/IIa Study of Cabazitaxel Plus Bavituximab in Castration-resistant Prostate Cancertreatment1 / 2terminated
NCT01261572
Study to Find Maintenance Dose for Periodic Administration of ASP3550treatment2completed
NCT05999968
Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatmenttreatment1active_not_recruiting
NCT04790968
Combined PSMA PET/MRI for Detection of Lymph Node Metastases in High-risk Prostate Cancer PatientsNo drug interventionsdiagnosticNot Availablerecruiting
NCT04854369
68Ga-PSMA-11 Patients With Newly Diagnosed and Recurrent Prostate Cancer (Firefly)No drug interventionsNot AvailableNot Availableno_longer_available
NCT02952469
Biodistribution/Reproducibility Ga-68 PSMA-HBED-CCdiagnostic0completed
NCT02632669
Hemi-Ablative Prostate BrachytherapyNo drug interventionstreatmentNot Availablecompleted
NCT01565746
Safety, Biodistribution, Radiation Dosimetry and Pharmacokinetics Study of BAY88-8223 in Japanese Patientstreatment1completed
NCT02283346
Single Fraction HDR Brachytherapy Plus Hypofractionated EBRT for Low-risk Prostate Cancer: Phase II TrialNo drug interventionstreatment2unknown_status
NCT00473512
A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapytreatment1 / 2completed
NCT04693910
Multimedia-based Hormonal Therapy Information Program for Patients With Prostate CancerNo drug interventionshealth_services_researchNot Availablecompleted
NCT00537381
An Efficacy and Safety Study of Intetumumab (CNTO 95) in Participants With Metastatic Hormone Refractory Prostate Cancertreatment2completed
NCT00188695
Combidex USPIO - Ultra-small Superparamagnetic Iron OxideNo drug interventionsdiagnostic1 / 2completed
NCT04034095
A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-naïve Prostate Cancer in JapanNot AvailableNot Availableactive_not_recruiting
NCT02363855
Phase 1 Dose Escalation Study of BAY 1841788 in Japanese Metastatic Castration-resistant Prostate Cancer (mCRPC) Subjectstreatment1completed
NCT01929655
Japanese BAY88-8223 Monotherapy Phase II Studytreatment2completed
NCT05616650
Focal Therapy With Stereotactic Body Radiation Therapy (SBRT) for Patients With a Single Prostate Tumortreatment2recruiting
NCT06136650
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)treatment3recruiting
NCT02606123
Safety and Anti-Tumor Study of Oral EPI-506 for Patients With Metastatic Castration-Resistant Prostate CancerNo drug interventionstreatment1 / 2terminated
NCT03064308
The Assessment of the Feasibility of a Home Based Exercise Programme in the Older Patient Following Major SurgeryNo drug interventionsotherNot Availablecompleted
NCT02546908
A Registry of Participants With Prostate Cancer in AsiaNo drug interventionsNot AvailableNot Availablecompleted
NCT04108208
A Study of Apalutamide in Chinese Participants With Non Metastatic Castration Resistant Prostate Cancer (NM-CRPC)treatment4active_not_recruiting
NCT00188708
Effect of Casodex on Tumour Hypoxia - Prostate CancerNo drug interventionsdiagnosticNot Availablecompleted
NCT00373308
Quality of Life Following Radical ProstatectomyNo drug interventionsNot AvailableNot Availablecompleted
NCT02833038
Effect of Intravenous Magnesium During Robot Assisted ProstatectomypreventionNot Availablecompleted
NCT03523338
An Expanded Access Protocol for Apalutamide Treatment of Participants With Non-Metastatic Castration-Resistant Prostate CancerNot AvailableNot Availableno_longer_available
NCT00230438
External Beam Radiation Therapy - Target VolumeNo drug interventionstreatment2completed
NCT00242138
Erectile Dysfunction/Prostate/RT/AndrogenNo drug interventionsNot Available2completed
NCT01365143
Prospective Randomized Trial Comparing Robotic Versus Open Radical ProstatectomyNo drug interventionstreatment4terminated
NCT00485303
An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapytreatment2completed
NCT01306890
A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate CancerNot AvailableNot Availablecompleted
NCT01934790
Re-treatment Safety of Radium-223 Dichloride in Castration-resistant Prostate Cancer With Bone Metastasestreatment1 / 2completed
NCT05755490
PROWESS (PROstate Cancer Wearables Exercise and Structured Supports): A Pilot Supportive Care InterventionNo drug interventionssupportive_careNot Availablenot_yet_recruiting
NCT02710721
Fasting and Nutritional Therapy in Patients With Advanced Metastatic Prostate CancerNo drug interventionssupportive_careNot Availablecompleted
NCT03961321
Stereotactic MR-guided Adaptive Radiation Therapy for Localized Prostate CancerNo drug interventionsNot AvailableNot Availablecompleted
NCT04248621
Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patientssupportive_care4unknown_status
NCT00923221
Collection of Blood From Patients With Prostate CancerNo drug interventionsNot AvailableNot Availablerecruiting
NCT01186484
Phase 1 Study of Abiraterone Acetate in Castration-resistant Prostate Cancertreatment1completed
NCT00113984
Vaccine and Antibody Treatment of Prostate Cancertreatment1completed
NCT02190279
18F-DCFBC PET/CT in Prostate Cancerdiagnostic0completed
NCT04573179
Effectiveness of 68Ga-PSMA PET/MRI for Improving the Detection of csPCa in Lesions With PI-RADS Score 3No drug interventionsNot AvailableNot Availableunknown_status